BFA
ALXA

BlackRock Fund Advisors’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

BlackRock Fund Advisors’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,525
Closed -$2K – 4359
2016
Q1 		$2K Buy
4,525
+924
+26% +$404 ﹤0.01% 4258
2015
Q4 		$3K Buy
+3,601
New +$3.71K ﹤0.01% 4272
2015
Q2 		– Sell
-63,350
Closed -$131K – 3936
2015
Q1 		$131K Sell
63,350
-4,288
-6% -$8.8K ﹤0.01% 3579
2014
Q4 		$101K Buy
67,638
+4,824
+8% +$8.61K ﹤0.01% 3618
2014
Q3 		$146K Sell
62,814
-4,556
-7% -$17.4K ﹤0.01% 3573
2014
Q2 		$308K Buy
67,370
+1,928
+3% +$8.32K ﹤0.01% 3331
2014
Q1 		$290K Buy
65,442
+7,953
+14% +$40.8K ﹤0.01% 3365
2013
Q4 		$272K Buy
57,489
+2,410
+4% +$11.8K ﹤0.01% 3354
2013
Q3 		$282K Buy
55,079
+19,148
+53% +$90.1K ﹤0.01% 3289
2013
Q2 		$156K Buy
+35,931
New +$163K ﹤0.01% 3411

BlackRock Fund Advisors's ALXA Position: Q2 2016 in Review

BlackRock Fund Advisors sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 4,525 shares — an estimated $2K sold.

BlackRock Fund Advisors first reported a position in ALXA in Q2 2013 and held it in 10 quarters. The position peaked at $308K in Q2 2014. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

  • BlackRock Fund Advisors reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • BlackRock Fund Advisors sold 4,525 Alexza Pharmaceuticals Inc shares in Q2 2016, an estimated $2K.
  • BlackRock Fund Advisors first reported a position in Alexza Pharmaceuticals Inc in Q2 2013 and held it in 10 quarters.
  • BlackRock Fund Advisors's Alexza Pharmaceuticals Inc position peaked at $308K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on BlackRock Fund Advisors's 13F filing for Q2 2016, filed 10 Aug 2016.